[Edaily Reporter Kwon Oh Seok ] #QuadMedicine Inc., a company specializing in pharmaceutical microneedle platforms, is accelerating its push into the global market by rapidly expanding the technological expertise it has built up in the pharmaceutical and biotech sectors into the beauty and cosmetics market.

QuadMedicine Inc. announced on the 6th that it participated in “in-cosmetics Asia 2026,” a global cosmetics ingredients exhibition held at BITEC in Bangkok, Thailand, from the 3rd to the 5th (local time), where it unveiled its next-generation cosmetic ingredient delivery platform, “MELTRYX®.” At the event, the company simultaneously hosted an “Innovation Zone” exhibition and a “Technical Seminar” to showcase its research achievements and core technologies.
This participation in the exhibition is expected to mark a turning point in expanding the scope of microneedle technology—which had previously been limited to the fields of vaccines and protein-based pharmaceuticals—into the realm of high-performance cosmetics.
QuadMedicine Inc. is a company that has accumulated expertise in formulation design for vaccines, peptides, and small-molecule drugs, as well as in the manufacture of microstructures and aseptic quality control. Its strength lies in its platform competitiveness, which enables a seamless transition from research and development (R&D) to mass production, thanks to its in-house GMP (Good Manufacturing Practice) production infrastructure and process design technology.
The core technology developed based on these proprietary biotechnological capabilities is the “R-MAP (Rolling Microneedle Array Platform),” a rolling-type skin delivery platform. R-MAP is a platform designed to create microchannels by rolling soluble microstructures across the skin’s surface, allowing them to dissolve naturally upon contact with moisture. The company is currently accelerating its expansion into topical pharmaceuticals—such as hair loss treatments—through preclinical trials using Clascoterone and Minoxidil.
The newly unveiled “MELTRYX” is a platform exclusively for cosmetics that adapts R-MAP’s rolling structure and microneedle design for the beauty sector. By utilizing the principle where star-shaped hexagonal prism structures make close, multidirectional contact with the skin and dissolve precisely in a moist environment, it significantly increases the skin penetration rate of active cosmetic ingredients.
A representative of QuadMedicine Inc. emphasized, “While providing customized delivery solutions tailored to each sector—from pharmaceuticals to cosmetics—we will continue to identify new business opportunities through partnerships with global companies.”